| 000 | 01609 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517201433.0 | ||
| 264 | 0 | _c20180406 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0192703 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIslam, Zhahirul | |
| 245 | 0 | 0 |
_aFAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome. _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0192703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBangladesh |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aFas Ligand Protein _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aG(M1) Ganglioside _ximmunology |
| 650 | 0 | 4 |
_aGuillain-Barre Syndrome _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeripheral Nervous System _xpathology |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_afas Receptor _xblood |
| 700 | 1 | _aJahan, Israt | |
| 700 | 1 | _aAhammad, Rijwan U | |
| 700 | 1 | _aShahnaij, Mohammad | |
| 700 | 1 | _aNahar, Shamsun | |
| 700 | 1 | _aMohammad, Quazi D | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 2 _gp. e0192703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0192703 _zAvailable from publisher's website |
| 999 |
_c28075114 _d28075114 |
||